jacketsndisney: Totally agree with your analysis re BP's current inability to justify a 5b offer, bur I believe the likelihood of CYDY's bod accepting 5b is also a non starter. I think that the CYDY bod believes, justifiably, that Leronlimab is worth several multiples of 5b. For a realistic BO negotiation to occur in 2020, a combination of several potential catalysts needs to occur. Many have been suggested in recent (and past) posts: uplifting and institutional investment; granting of BTDs and the combo BLA, licensing deals (involving several indications and possibly coronavirus). IMO, only when the mc has been moved to between 5 and 10b, is a meeting of minds possible with the half dozen or so BP companies that could meet the price.